baber/WOPTO huggingface dataset:
Patent AU-579582-B2 (AU)
Title: Electro acoustic transducer
Inventor: TAYLOR FRANK
IPC: H04R31/00
Filed: 1984-08-14
Granted: 1988-12-01
Abstract: A moving coil capsule for a telephone handset is designed for high speed mass production, It consists of a carrier ring (1) and diaphragm (2) formed as an interim sub-assembly in a first buffer store. A coil (6) preparation and finishing stage applies the coil (6) on a former in the form of an aluminium dome (5) and inserts the dome (5) into a nest (7) in the diaphragm to form a first sub-assembly in a second buffer store. A magnet assembly (10,11 and 12) is manufactured using quick curing glue with the outer pole piece (12) formed by an accurate stamping whose outer rim fits precisely in a reference datum (1a) in the carrier ring.The interim sub-assemblies and magnet assemblies are made one at a time, and the first sub-assemblies are formed two at a time from the interim sub-assemblies, but at half the speed.Final assembly of the magnet assembly and first sub-assembly together with a rear cover (14) is carried out and a throughput at a rate of one capsule in less than four seconds can be achieved.
Patent AU-562423-B2 (AU)
Title: Benzoic acid derivatives
Inventor: DEMARNE HENRI
IPC: C07C69/92
Filed: 1984-08-15
Granted: 1987-06-11
Abstract: Benzoic acid derivatives with the general formula:    <IMAGE>  (I) in which: A represents a straight or branched alkyl chain with 5 to 10 carbon atoms, X represents the oxygen atom or a direct bond, R represents hydrogen or an alkyl group with 2 to 6 carbon atoms, possibly substituted by an alcohol function, and the salts of the said derivatives. These derivatives display antimicrobial activity and are suitable as antiseptics, disinfectants and preservatives, particularly in the fields of pharmaceuticals, cosmetology and agri-foodstuffs.
Patent AU-716513-B2 (AU)
Title: Respiratory effort detection method and apparatus
Inventor: CHRISTOPHERSON MARK A
IPC: A61B5/113
Filed: 1997-06-26
Granted: 2000-02-24
Abstract: A method of predicting critical points in patient respiration includes monitoring at least one characteristic of a respiratory effort waveform of a patient to detect a respiratory event. A refractory period is defined that includes a hard refractory period during which time the respiratory event cannot be responded to and a soft refractory period following the hard refractory period. The respiratory event outside of the refractory period is detected as a function of a first set of predetermined parameters for the monitored at least one characteristic and the respiratory event within the soft refractory period is detected as a function of a second set of predetermined parameters for the monitored at least one characteristic. The respiratory event may be inspiration onset and the characteristic of the respiratory effort waveform monitored is at least one of slope and amplitude. The refractory period may be defined based on detection of inspiration offset and further may be defined based on inspiration offset, an average respiratory period, and an average time of inspiration. Further, stimulation may be provided in response to a detected inspiration onset. Another method of predicting critical points includes sampling the amplitude of the respiratory effort waveform of a patient. A sample signal is generated representative of at least one characteristic of the respiratory effort waveform based on each amplitude sample. The sample signals representative of the at least one characteristic of the respiratory effort waveform are monitored and a respiratory event is detected as a function of at least two sample signals. Apparatus and systems for use with such methods are also described.
Patent AU-721358-B2 (AU)
Title: Probes for detecting and identifying helicobacter pylori
Inventor: KESHI HIROYUKI
IPC: C12Q1/68
Filed: 1997-07-24
Granted: 2000-06-29
Abstract: Probes for specifically detecting and identifying Helicobacter pylori which serves as an inflammatory bacterium in digestive diseases. These probes contain a fragment formed by completely digesting a DNA carried by H. pylori with a restriction enzyme HindIII. The information of the base sequences of these probes are useful as a structural indication of primers to be used in the construction of probes specific to H. pylori by PCR or as standard sequences suitable for the comparison with genomic DNAs contained in clinical specimens. <IMAGE>
Patent AU-748885-B2 (AU)
Title: Display system having a number of light emitters and holders for the light emitters
Inventor: LEIJER ANTONIUS LAURENTIUS DE
IPC: H05B37/02
Filed: 1997-08-15
Granted: 2002-06-13
Abstract: Display system comprising a number of lamp holders which each have a local control unit and which are suitable for holding and connecting to the local control unit a lamp, the local control units of the various lamp holders being connected to a common conductor bundle to which a central control unit and a supply unit are also connected. Each local control unit contains an address. If a local control unit receives a message containing the address of the local control unit from the conductor bundle it responds, depending on any other content of the message, for optionally activating the associated lamp, for optionally changing the address and for sending back a message which specifies the conducting state between connections for the lamp.
Patent AU-566359-B2 (AU)
Title: 5-oxo-3/beta (un/substituted phenyl) -2- pyrrolidine propanoic acid
Inventor: BUTLER DONALD E
IPC: C07D207/267
Filed: 1985-04-17
Granted: 1987-10-15
Abstract: Compounds of formula I or II 
<CHEM>
 wherein R is a hydrogen, a pharmaceutically acceptable metal or amine cation, an alkyl radical of from one to six carbon atoms, a phenyl radical, or a phenylmethyl radical; and wherein X and Y are independently a hydrogen, an alkyl radical of from one to six carbon atoms, an alkoxy radical of from one to six carbon atoms, a chlorine or a trifluoromethyl radical. A process for preparing the compounds and pharmaceutical compositions comprising the compounds are also disclosed, The compounds are useful in the treatment of senility and for reversing amnesia.
Patent AU-700492-B2 (AU)
Title: Method of applying phosphate coatings to metal surfaces
Inventor: WENDEL THOMAS
IPC: C23C22/36
Filed: 1995-12-05
Granted: 1999-01-07
Abstract: PCT No. PCT/EP95/04774 Sec. 371 Date Jun. 6, 1997 Sec. 102(e) Date Jun. 6, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/17977 PCT Pub. Date Jun. 13, 1996A method is disclosed for applying phosphate coatings to surfaces of zinc, iron, aluminum, and the alloys thereof by wetting with a phosphatizing solution containing divalent cations and phosphate to form a liquid film, and subsequently drying on the liquid film wherein the metal surfaces are wetted with a phosphatizing solution, which is free from elements of sub-groups 5 and 6 of the Periodic Table, said phosphatizing solution containing: 0.5 to 8 g/l nickel; 2 to 20 g/l manganese; 18 to 170 g/l of phosphate (calculated as P2O5); and has an acid number of 0.4 to 0.8, such that after drying on, a phosphate layer having a weight per unit area of 0.3 to 3.0 g/m2, is obtained, where in the case of phosphatizing surfaces of iron, aluminum or the alloys thereof, the phosphatizing solution necessarily contains 0.5 to 5 g/l of zinc, and in the case of phosphatizing surfaces of zinc or zinc alloys the phosphatizing solution either contains zinc or is free from zinc.
Patent AU-743598-B2 (AU)
Title: Molding powder for continuous casting of thin slab
Inventor: MORITA AKIHIRO
IPC: B22D11/111
Filed: 1999-07-16
Granted: 2002-01-31
Abstract: A mold powder characterized in that, a weight ratio of CaO to SiO2 in the mold powder is within a range of 0.50 to 1.20, the mold powder contains one or two or more species selected from a group consisting of oxides, carbonates, or fluorides of alkali metals, alkaline earth metals, or other metals, and 0.5 to 5 percent by weight of carbon powder, Li2O content is within a range of 1 to 7 percent by weight, F content is within a range of 0.5 to 8.0 percent by weight, crystallization temperature is within a range of 1000 to 1200 DEG C, surface tension at 1300 DEG C is 250 dyne/cm or more, and a relationship between viscosity  eta  (poise) at 1300 DEG C and casting speed V (m/min) satisfies a range represented by an expression 6.0 </=  eta V </= 100.0. By the present invention, there is provided a mold powder which enables stable casting by reducing the likelihood of powder entrapment into the mold without giving rise to surface crack when casting with a thin-slab continuous caster.
Patent AU-670966-B2 (AU)
Title: Combination of germicidal agents
Inventor: KLEIN WINFRIED
IPC: A01N63/02
Filed: 1993-08-20
Granted: 1996-08-08
Abstract: Combinations of imidazol and/or one or more imidazol derivatives with general structural formula (I) in which the residues may be as follows: R1 = H, C(1 - 25) alkyl, R2 = H, C(1 - 25) alkyl, R3 = H, C(1 - 25) alkyl, R4 = H, C(1 - 25) alkyl, where R4 may also, and preferably when R1, R2 and R3 are a hydrogen atom, be the residues -CH2-CH2-NR5R6 and -CH2-CH(NR5R6)-COOR7, where R5 = H, C(1 - 25) alkyl, R6 = H, C(1 - 25) alkyl, R7 = H, C(1 - 25) alkyl, and of a substance active against micro-organisms or a mixture from the lantibiotics group.
Patent AU-780400-B2 (AU)
Title: Methods for treating diabetes
Inventor: SOMMER ANDREAS
IPC: A61P3/10
Filed: 2000-05-23
Granted: 2005-03-17
Abstract: The invention provides new methods for the treatment of diabetes mellitus, including type I, type II, and insulin resistant diabetes (both type I and type II). The methods of the invention employ administration of rhIGF-I/IGFBP-3 complex to a subject suffering from the symptoms of diabetes mellitus. Administration of rhIGF-I/IGFBP-3 to a subject suffering from the symptoms of diabetes mellitus results in amelioration or stabilization of the symptoms of diabetes.
Patent AU-591098-B2 (AU)
Title: Measurement of optical density via nephelometry
Inventor: PUMPHREY JOHN G
IPC: G01N21/49
Filed: 1986-02-26
Granted: 1989-11-30
Abstract: 57 A method for measuring the formation of optical density at 350 to 700 nm in a material is disclosed. The method comprises directing through a solution of the material with light-scattering means suspended therein a beam of light having a wavelength in the range of 350 to 700 nm at which the material absorbs light, and measuring the scattered intensity of the light leaving the solution at a given angle.
Patent AU-730120-B2 (AU)
Title: Radioactive transition metal nitride heterocomplex
Inventor: DUATTI ADRIANO
IPC: C07F13/00
Filed: 1997-12-16
Granted: 2001-02-22
Abstract: The present invention provides a single radioactive transition metal nitride heterocomplex which permits labeling of a physiologically active substance such as a peptide, hormone or the like without impairing the activity of the substance. The radioactive transition metal nitride heterocomplex of the present invention is represented by the following formula (I): (M IDENTICAL N)XY wherein a radioactive transition metal M is radioactive technetium or radioactive rhenium, N is a nitrogen atom, X is a diphosphine compound or a diarsine compound, and Y is a bindentate ligand having a combination of electron-donating atoms. <IMAGE>
Patent AU-645751-B2 (AU)
Title: Enzyme inhibiting peptide derivatives
Inventor: ANDERSON PAUL CATES
IPC: C12N9/99
Filed: 1990-06-05
Granted: 1994-01-27
Abstract: Disclosed herein are peptide derivatives which inhibit the activities of human immunodeficiency virus (HIV) protease and renin. The peptide derivatives can be represented by general formula R<1>-R<2>-Y-R<3>-R<4> wherein R<1> is a derived amino acid based on an O<4>-(carboxymethyl)-tyrosyl residue, R<2> and R<3> are amino acid or analogous amino acid residues (R<3> may optionally be absent), Y is a non-peptide linking unit, e.g. statyl, and R<4> is [NR<1><7>CHR<1><8>-C(O)]p-Z wherein R<1><7> is hydrogen or lower alkyl, R<1><8> is an amino acid or analogous amino acid side chain, p is zero or one and Z is a terminal group (e.g. hydroxy or amino), or R<4> is NR<1><7>CR<1><8>(R<2><1>)CH2OH wherein R<1><7> and R<1><8> are as noted hereinabove and R<2><1> is hydrogen, lower alkyl or hydroxy-(lower)alkyl. The derivatives are useful as agents for combating HIV infections and for treating renin-associated hypertension and congestive heart failure.
Patent AU-736837-B2 (AU)
Title: Adhesive for secure topical attachment to the skin and comfortable removal
Inventor: CINELLI FABIO
IPC: C09J133/08
Filed: 1997-12-22
Granted: 2001-08-02
Abstract: The present invention relates to topical adhesives for attachment to the skin. In particular the present invention relates to such topical adhesives which can be employed for attachment to the skin of protective articles, clothing, prosthesis, heat wraps, pads, and/or packs, e.g. for topical relief of pain or simply to provide warmth; cold wraps, hearing aids, protective face masks, ornamental articles, or eye wear but excluding absorbent articles. The topical adhesive provides secure attachment and is pleasing to the skin upon application, yet causes no discomfort upon removal. This is achieved by selecting the chemical composition and rheological characteristics of the topical adhesives.
Patent AU-682021-B2 (AU)
Title: Process for the manufacture of alkyl ketene dimers by dimerization with tertiary amines
Inventor: ZHANG JIAN JIAN
IPC: C07B41/06
Filed: 1994-03-25
Granted: 1997-09-18
Abstract: A process is disclosed for the synthesis of alkyl ketene dimers by the dehydrohalogenation of a C6 - C22 saturated or unsaturated linear fatty acid halide, comprising reacting the fatty acid chloride with a cyclic tertiary amine in an inert solvent at a temperature of up to 75 DEG , separating tertiary amine hydrochloride salts from alkyl ketene dimer dissolved in the solvent, and recovering the alkyl ketene dimer from the solvent.
Patent AU-670677-B2 (AU)
Title: Pin for securing a replacement ligament to a bone
Inventor: GOBLE E MARLOWE
IPC: A61B17/58
Filed: 1994-01-13
Granted: 1996-07-25
Abstract: A pin is provided for securing a replacement ligament inside a tunnel of a receptor bone. The pin includes a body portion having a threaded section for engaging the receptor bone to anchor the pin in the receptor bone. The body portion also includes a tapered shank located adjacent the threaded portion. The tapered shank is configured to enter a drilled hole having a predetermined diameter formed in the replacement ligament to force the replacement ligament against the wall of the tunnel. The tapered shank has a first diameter at a first end of the tapered shank opposite the threaded portion which is smaller than the predetermined diameter of the drilled hole and a second diameter adjacent the threaded portion which is larger than the predetermined diameter so that the tapered shank engages the replacement ligament in the tunnel as the pin is inserted through the drilled hole in the replacement ligament to force the replacement ligament against a side wall of the tunnel to promote healing of the replacement ligament within the receptor bone. The pin further includes a head coupled to an end of the body portion adjacent the threaded section for driving the pin into the receptor bone.
Patent AU-534359-B2 (AU)
Title: Polycarbonate block copolymers
Inventor: BEHNKE JOACHIM
IPC: C08G63/66
Filed: 1980-08-13
Granted: 1984-01-26
Abstract: A method for production of polycarbonate-polyether-blockcopolymers is provided. One or more solutions comprising bisphenol A and polyalkyleneglycol and a phosgene solution are added to a cooled initial reaction medium in a cooled reaction chamber in such a way that the phosgene contacts substantially the reaction partners from the one or more cooled solutions after they have spread in the reaction medium. Preferably the phosgene solution and the one or more solutions are added through tubes ending above the liquid level of the reaction medium such that the solutions added contact only within the stirred reaction mixture the reaction partner. The phosgene is employed in an excess of less than about 10 weight percent of the stochiometrically required weight amount relative to bisphenol A and polyalkyleneglycol. The polymer is useful in the production of membranes for dialysis, ultrafiltration and reverse osmosis.
Patent AU-624310-B2 (AU)
Title: Intra-arterial stent with the capability to inhibit intimal hyperplasia
Inventor: FISCHELL ROBERT E
IPC: A61K51/12
Filed: 1990-12-11
Granted: 1992-06-04
Abstract: Disclosed is a means of preventing restenosis of an artery at a trauma site due to intimal hyperplasia. That device comprises a thin wire with a radioactive tip that can temporarily be introduced into the artery and left at the trauma site for a limited period of time.
Patent AU-687410-B2 (AU)
Title: Device for detaching sclerotic plaques by means of ultrasound and treatment set with such a device
Inventor: ROSA ANTONIO LA
IPC: A61B17/00
Filed: 1994-05-28
Granted: 1998-02-26
Abstract: An apparatus, provided with an ultrasound transmitter connectable to an ultrasound generator (17), for detaching atherosclerotic plaque by means of ultrasonic vibrations, comprises a probe (7; 8) fastened on a handle (1). The probe (7; 8) comprises an essentially transversally oscillating working part and an essentially longitudinally oscillating transmission part. The transmission part is completely enclosed by a tube carrying liquid which serves to wet the working part of the probe (7; 8), a channel being provided in the handle (1) for supply of liquid into the tube. The tube is made of a material whose coefficient of friction is negligible relative to the liquid, and there are means for wetting the working part with liquid on all sides. <IMAGE>
Patent AU-713242-B2 (AU)
Title: Novel composition containing an acid-labile omeprazole and process for its preparation
Inventor: SETH PAWAN
IPC: A61K9/50
Filed: 1996-09-23
Granted: 1999-11-25
Abstract: A pharmaceutical composition exempt of alkaline-reacting compounds comprising :     (a) a core containing an acid-labile omeprazole active principle,   (b) an intermediate layer ; and   (c) an enteric layer ; with the proviso that said composition is not an oral pharmaceutical multiple unit tableted dosage form comprising tablet excipients and individually enteric coating layered units of a core material containing omeprazole, covered with one or more layer (s) of which at least one is an enteric coating layer, whereby the enteric coating layer has mechanical properties such that the compression of the multiple unit tableted dosage form does not significantly affect the acid resistance of the individually enteric coating layered units.  Process for preparing a composition. <IMAGE>   <IMAGE>   <IMAGE>
Patent AU-601724-B2 (AU)
Title: Method and apparatus for detecting position of tape when recording or reproducing signals thereon
Inventor: YAMANAKA MASAAKI
IPC: G11B27/10
Filed: 1987-04-07
Granted: 1990-09-20
Abstract: In recording and/or reproducing signals on a tape (13) running between supply (14) and take-up reels (15) on which the tape (13) is wound, the tape position is detected by initially determining the radii of the outer turns of the tape (13) on the supply (14) and take-up reels (15) with the tape in a reference position, generating signal pulses in response to rotation of the reels (14, 15) for movement of the tape (13) from the reference position, counting the numbers of such signal pulses generated during movement of the tape (13) from the reference position to an arbitrary tape position, and calculating at least one of the radii of the outer turns of the tape (13) on the supply (14) and take-up reels (15) for the arbitrary tape position on the basis of the corresponding radii for the reference tape position and the numbers of the signal pulses counted during movement of the tape (13) from the reference position to the arbitrary tape position. The length along the tape (13) from the reference tape position to the arbitrary tape position may also be calculated on the basis of the radii on the supply (14) and take-up reels (15), respectively, for the reference tape position, and the numbers of signal pulses counted in correspondence to the revolutions of the supply (14) and take-up reels (15), respectively, during movement of the tape (13) from the reference position to the arbitrary tape position.
Patent AU-599100-B2 (AU)
Title: 1,4-disubstituted piperazine derivatives, pharmaceutical compositions containing them and process for preparing same
Inventor: TOTH EDIT
IPC: A61P25/00
Filed: 1987-04-28
Granted: 1990-07-12
Abstract: The invention relates to novel 1,4-disubstituted piperazine derivatives of the general formula (I), pharmaceutically acceptable acid addition and quaternary ammonium salts thereof, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)    <IMAGE>  (I)  R1, R2, R3 and R4 are the same or different and stand for hydrogen or halogen or a trihalomethyl, lower alkyl, lower alkoxy, nitro, hydroxyl, aralkyloxy or an 1-(2-propenyl-4-piperazinyl) group; R5 stands for hydrogen or a C1-4 alkyl group; R6 represents a C3-6 alkyl, alkenyl, alkynyl group or a   <IMAGE>   group, wherein R7 means a C2-5 alkyl, alkenyl or alkinyl group; and is 2 or 3, with the provisos that: R6 is different from isopropyl, n-butyl and isobutyl group when R2, R3, R4 and R5 stand for hydrogen, R1 means 2-chloro and n is 2; R6 is different from isopropyl group when R2, R3, R4 and R5 stand for hydrogen, R1 means 2-chloro and n is 2; or when R2, R3, R4 and R5 stand for hydrogen, R1 means 2-methyl group and n is 2; and R6 is different from propionyl group when R1, R2, R3, R4 and R5 are hydrogen and n means 2. The compounds of the general formula (I) are therapeutically useful for the treatment of diseases arising from a hypofunction of the dopaminergic system.
Patent AU-615877-B2 (AU)
Title: Indoloquinone compounds
Inventor: SPECKAMP WILLEM NICO
IPC: C07D403/04
Filed: 1987-04-15
Granted: 1991-10-17
Abstract: PCT No. PCT/GB87/00253 Sec. 371 Date Nov. 23, 1988 Sec. 102(e) Date Nov. 23, 1988 PCT Filed Apr. 15, 1987 PCT Pub. No. WO87/06227 PCT Pub. Date Oct. 22, 1987.Indoloquinone compounds useful as cytostatic agents have formula (I), where R2 and R3 are in each case, hydrogen, halogen, an alkyl group (which may be substituted), an alkoxy group or an aryloxy group, an alkylthio group or an arylthio group, a primary or secondary amino group, hydroxy group or an amino group; R5 is hydrogen, a hydroxy group, an alkoxy group, an alkyl group (which may be substituted), or a carbohydrate moiety; R6 and R7 are in each case hydrogen, halogen, or an alkyl group; R8 is a group -CH2X1, a group -CO2-M+, where M+ is a metal ion; a group -CO2R10, where R10 is hydrogen or an alkyl group (which may be substituted); a group -CONR'R'', where R' and R'' are hydrogen or alkyl groups (which may be substituted); R9 is a group -CR11R12X2, a group -CO2-M+, where M+ is a metal ion; a group -CO2R13, where R11, R12 and R13 are in each case hydrogen or an alkyl group (which may be substituted); a group -CONR'R'', where R' and R'' are in each case hydrogen or an alkyl group (which may be substituted), and X1 and X2 (when present) are hydrogen, or groups selected from OH, OR, -OC=OR, -OCO2R, -OC=ONRR, SH, SR, -SC=OR, -SC=SR, -SCO2R, -SC=SOR, -SC-ONRR, -SC-SNRR, and -NRR [where R is hydrogen, an alkyl group (which by be substituted), or an aryl group (which may be substituted)], -OSOR, -OSO2R and OP(OR)2 [where R is hydrogen, an alkyl group (which may be substituted,), an aryl group (which may be substituted), or a carbohydrate moiety]; and X1 and X2 may be the same or different. Preferred compounds and methods for their manufacture are provided.